Zykadia recommended for approval in advanced non small cell lung cancer

View source ↗

Summary

The European Medicines Agency recommended approving Zykadia for use in adults with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Zykadia (ceritinib)